Program Guide | Fellows 2024
Fellows 2024
Fellows 2024
People who live in rural areas get sicker and die sooner than people in urban areas. But the American Heart Association – working with people…
Identifying signatures or metrics to guide patient-specific atrial fibrillation (AF) ablation approaches is paramount for improving outcomes beyond pulmonary vein isolation. These approaches assume that…
Join us in recognizing the American Heart Association’s 2024 National Volunteer Awardees. Together, let’s celebrate the power of volunteerism and the impact …
Disruptions in endothelial function caused by brief bouts of elicited anger may be an early predictor of heart disease, but the underlying mechanism remains unclear,…
In the present analysis of two observational population-based cohorts of middle-aged to older adults, the coronary artery calcium (CAC) score provided better discrimination for coronary…
The Cochrane Heart, Stroke and Circulation Thematic Group has recently been awarded a pivotal grant from the Academy of Medical Sciences. The grant will enhance…
BACKGROUND: Previous meta-analyses resurrected the debated statement “the lower, the better” following blood pressure (BP)-lowering treatment. We investigated the benefits of BP-lowering treatment at
This conversation highlights the key points from this article focusing on the hemodynamic profile of the developed intravascular pumps and their application …
ATLANTA — Obicetrapib, a novel cholesteryl ester transfer protein inhibitor, reduced atherogenic lipoprotein particles alone or in combination with ezetimibe, according to new data from…
ATLANTA — For patients with nonobstructive hypertrophic cardiomyopathy, ninerafaxstat, a novel cardiac mitotrope, safely improved HF symptoms during a 12-week period vs. placebo, a speaker…